| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8837447 | Surgery | 2018 | 6 Pages |
Abstract
Ubiquitin carboxyl-terminal hydrolase L1 is a novel biomarker for identifying malignant potential of primary well-differentiated and moderately differentiated pancreatic neuroendocrine tumors and in combination with Ki67 is an independent predictor of development of metastatic disease.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Maureen D. MD, Brendan MD, Katherine D. MD, Rana MBBS, Yi-Fan MD, Lauren BS, Toni MD, Rema MD, Rasa MD, Thomas J. MD,